company background image
2603

Shijiazhuang Yiling Pharmaceutical SZSE:002603 Stock Report

Last Price

CN¥22.84

Market Cap

CN¥38.2b

7D

7.9%

1Y

18.2%

Updated

08 Aug, 2022

Data

Company Financials +
2603 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health5/6
Dividends4/6

2603 Stock Overview

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Shijiazhuang Yiling Pharmaceutical
Historical stock prices
Current Share PriceCN¥22.84
52 Week HighCN¥43.12
52 Week LowCN¥15.38
Beta-0.074
1 Month Change-9.04%
3 Month Change-13.84%
1 Year Change18.16%
3 Year Change212.57%
5 Year Change91.36%
Change since IPO86.07%

Recent News & Updates

Shareholder Returns

2603CN PharmaceuticalsCN Market
7D7.9%1.2%-0.5%
1Y18.2%-15.8%-10.4%

Return vs Industry: 002603 exceeded the CN Pharmaceuticals industry which returned -15.8% over the past year.

Return vs Market: 002603 exceeded the CN Market which returned -10.4% over the past year.

Price Volatility

Is 2603's price volatile compared to industry and market?
2603 volatility
2603 Average Weekly Movement6.6%
Pharmaceuticals Industry Average Movement5.6%
Market Average Movement6.1%
10% most volatile stocks in CN Market9.2%
10% least volatile stocks in CN Market3.9%

Stable Share Price: 002603 is not significantly more volatile than the rest of CN stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 002603's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199215,155Xiang Jun Wuhttps://www.yiling.cn

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others.

Shijiazhuang Yiling Pharmaceutical Co., Ltd. Fundamentals Summary

How do Shijiazhuang Yiling Pharmaceutical's earnings and revenue compare to its market cap?
2603 fundamental statistics
Market CapCN¥38.16b
Earnings (TTM)CN¥1.15b
Revenue (TTM)CN¥9.17b

33.1x

P/E Ratio

4.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
2603 income statement (TTM)
RevenueCN¥9.17b
Cost of RevenueCN¥3.45b
Gross ProfitCN¥5.72b
Other ExpensesCN¥4.57b
EarningsCN¥1.15b

Last Reported Earnings

Mar 31, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.69
Gross Margin62.38%
Net Profit Margin12.58%
Debt/Equity Ratio11.9%

How did 2603 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

43%

Payout Ratio